You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GS-1101

Showing 26 - 50 of 381
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial (Teropavimab, Zinlirvimab, Lenacapavir Tablet)

Not yet recruiting
  • HIV Infections
  • Teropavimab
  • +4 more
  • (no location specified)
Feb 6, 2023

Solid Tumors Trial (GS-9911, Zimberelimab)

Not yet recruiting
  • Solid Tumors
  • (no location specified)
Oct 9, 2023

Solid Tumor Trial (GS-4528, Zimberelimab)

Not yet recruiting
  • Solid Tumor
  • (no location specified)
Apr 21, 2023

STEMI - ST Elevation Myocardial Infarction Trial

Not yet recruiting
  • STEMI - ST Elevation Myocardial Infarction
    • (no location specified)
    Dec 24, 2022

    Myelodysplastic Syndrome Trial in Japan (SyB C-1101 and Azacytidine)

    Withdrawn
    • Myelodysplastic Syndrome
    • SyB C-1101 and Azacytidine
    • Nagoya, Aichi, Japan
    • +3 more
    Nov 14, 2022

    HIV-1 Infection Trial in United States (Oral Lenacapavir, Subcutaneous Lenacapavir, Teropavimab)

    Active, not recruiting
    • HIV-1 Infection
    • Oral Lenacapavir
    • +3 more
    • Los Angeles, California
    • +22 more
    Nov 4, 2022

    COVID-19 Trial (GS-5245, GS-5245 Placebo)

    Not yet recruiting
    • COVID-19
    • (no location specified)
    Feb 3, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Relapsed Chronic Lymphocytic Leukemia Trial in Boston (Acalabrutinib,

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • +3 more
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Dec 19, 2022

    Allergic Rhinitis Trial in Vienna (CAL-101, Placebo)

    Completed
    • Allergic Rhinitis
    • Vienna, Austria
      Vienna Challenge Chamber
    Oct 19, 2018

    Myelodysplastic Syndrome Trial in Japan (SyB C-1101)

    Completed
    • Myelodysplastic Syndrome
    • SyB C-1101
    • Nagoya, Aichi, Japan
    • +8 more
    Nov 14, 2022

    COVID-19 Trial in Canada, Poland, Romania (GS-5245, GS-5245 Placebo)

    Recruiting
    • COVID-19
    • Hamilton, Canada
    • +8 more
    Jan 24, 2023

    Advanced Refractory Solid Tumors Trial in Kaohsiung, Tainan (T-1101 (Tosylate))

    Recruiting
    • Advanced Refractory Solid Tumors
    • T-1101 (Tosylate)
    • Kaohsiung, Taiwan
    • +1 more
    Oct 31, 2021

    Myelodysplastic Syndrome Trial in Nagoya, Fukuoka, Tokyo (SyB L-1101)

    Completed
    Has Results
    • Myelodysplastic Syndrome
    • SyB L-1101
    • Nagoya, Aichi, Japan
    • +2 more
    Nov 14, 2022

    HIV-1-infection Trial in United States (GS-5894, B/F/TAF, Standard of Care)

    Recruiting
    • HIV-1-infection
    • Los Angeles, California
    • +15 more
    Jan 13, 2023

    Stroke Trial in Venice (real tACS, sham tACS)

    Recruiting
    • Stroke
    • real tACS
    • sham tACS
    • Venice, Italy
      IRCCS San Camillo Hospital
    Apr 13, 2023

    BRCA1/2 Flu Vaccine

    Active, not recruiting
    • BRCA1 Mutation
    • BRCA2 Mutation
    • Seasonal influenza vaccine
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Aug 16, 2022

    Extremes of Coronary Artery Disease and Normality:CAD Extremes

    Not yet recruiting
    • Coronary Artery Disease
    • Blood draw
    • (no location specified)
    Mar 7, 2023

    Advanced Solid Tumors Trial in United States (GS-3583)

    Active, not recruiting
    • Advanced Solid Tumors
    • Grand Rapids, Michigan
    • +3 more
    Jul 22, 2022

    Sexual Health Trial in Taoyuan (Received the GS-SHEP)

    Completed
    • Sexual Health
    • Received the GS-SHEP
    • Taoyuan, Guishan Dist., Taiwan
      Cheng Gung Memorial Hospital
    Mar 5, 2023

    Normative QEEG/ERP Data for Healthy Volunteers

    Not yet recruiting
    • Healthy
      • Louisville, Kentucky
        Cognision
      May 11, 2023

      Myelodysplastic Syndrome Trial in Japan (SyB C-1101)

      Completed
      Has Results
      • Myelodysplastic Syndrome
      • SyB C-1101
      • Nagoya, Aichi, Japan
      • +3 more
      Nov 14, 2022

      Follicular Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytic Lymphoma Trial in Worldwide (Idelalisib)

      Completed
      Has Results
      • Follicular Lymphoma
      • +3 more
      • Fullerton, California
      • +40 more
      Jun 14, 2019

      COVID 19 Disease, Mild to Moderate COVID 19 Disease, SARS-CoV-2 Trial (Tafenoquine Oral Tablet, Placebo)

      Not yet recruiting
      • COVID 19 Disease
      • +4 more
      • Tafenoquine Oral Tablet
      • Placebo
      • (no location specified)
      Jul 13, 2023

      Value of Uric Acid as Early Predictor of Lupus Nephritis

      Recruiting
      • Uric Acid
      • Serum uric acid level
      • Assuit, Egypt
        assuit University
      May 29, 2022

      Cutaneous Lupus Erythematosus Trial in United States (GS-5718, Placebo)

      Terminated
      • Cutaneous Lupus Erythematosus
      • Beverly Hills, California
      • +4 more
      Nov 17, 2022